Glucagon: role in the hyperglycemia of diabetes mellitus. 1975

R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger

Glucagon suppression by somatostatin reduces or abolishes hyperglycemia in dogs made insulin-deficient by somatostatin, alloxan, or total pancreatectomy. This suggests that the development of severe diabetic hyperglycemia requires the presence of glucagon, whether secreted by pancreatic or newly identified gastrointestinal A cells, as well as a lack of insulin. Glucagon suppression could improve therapeutic glucoregulation in diabetes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate

Related Publications

R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
January 1977, Annual review of medicine,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
October 1976, Scandinavian journal of clinical and laboratory investigation,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
July 1976, JPMA. The Journal of the Pakistan Medical Association,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
October 1975, JAMA,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
November 1952, Das Deutsche Gesundheitswesen,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
January 1981, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
May 1975, Diabetes,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
February 1953, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
January 1975, Lancet (London, England),
R Dobbs, and H Sakurai, and H Sasaki, and G Faloona, and I Valverde, and D Baetens, and L Orci, and R Unger
May 1993, American journal of hypertension,
Copied contents to your clipboard!